Publications by authors named "Youngsuk Lim"

Claim this Profile
E
Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment.
Grace Lai-Hung Wong, Edward Gane, Calvin Q Pan, Scott Fung, Mang M Ma, Shalimar, Seng Gee Lim, Young-Suk Lim

Aliment Pharmacol Ther· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transarterial Chemoembolization Alone versus Combined with Radiotherapy as First-Line Therapy for Early-Stage Single Hepatocellular Carcinoma.
Hye In Lee, Jinhong Jung, So Yeon Kim, Jonggi Choi, Danbi Lee, Young-Suk Lim

Int J Radiat Oncol Biol Phys· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abbreviated gadoxetic acid-enhanced MRI versus ultrasonography for HCC surveillance in high-risk patients: A randomized trial protocol.
Hyo Jung Park, Jonggi Choi, Dong Wook Kim, Sang Hyun Choi, Won-Mook Choi, Young-Suk Lim

Hepatol Commun· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elebsiran and PEG-IFNα for chronic hepatitis B infection: a partially randomized, open-label, phase 2 trial.
Grace Lai-Hung Wong, Man-Fung Yuen, Bingliang Lin, Mark W Douglas, Peng Hu, Young-Suk Lim

Nat Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Extrahepatic Malignancies in Patients With Autoimmune Hepatitis: A Nationwide Cohort Study.
Sung Won Chung, Ye-Jee Kim, Jihye Lim, Jonggi Choi, Danbi Lee, Young-Suk Lim

Am J Gastroenterol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-contrast magnetic resonance imaging for detection of late recurrent hepatocellular carcinoma after curative treatment: a prospective multicenter comparison to contrast-enhanced computed tomography.
Dong Wook Kim, Won Chang, So Yeon Kim, Young-Suk Lim, Jonggi Choi

Clin Mol Hepatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modelling Assumptions in Cost-Effectiveness Analysis of Antiviral Therapy for High Viremic Indeterminate Phase Chronic Hepatitis B.
Suk-Chan Jang, Won-Mook Choi, Hye-Lin Kim, Young-Suk Lim

Liver Int· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
15-Year Trends in Hepatocellular Carcinoma: Epidemiology, Treatment, and Outcomes from a Hospital-Based Registry.
Songgyung Kim, Jina Park, Won-Mook Choi, Danbi Lee, Ju Hyun Shim, Young-Suk Lim

Gut Liver· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Viral Load-Based Prediction of Hepatocellular Carcinoma Risk in Noncirrhotic Patients With Chronic Hepatitis B.
Gi-Ae Kim, Young-Suk Lim

Ann Intern Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of Antiviral Therapy in Patients With High Viremic Indeterminate Phase Chronic Hepatitis B.
Suk-Chan Jang, Won-Mook Choi, Gi-Ae Kim, Gwang Hyeon Choi, Yun Bin Lee, Young-Suk Lim

Liver Int· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching to tenofovir alafenamide in virally-suppressed chronic hepatitis B patients with renal/hepatic impairment: Phase 2 study sub-analysis from Taiwan.
Chun-Jen Liu, Young-Suk Lim, Chi-Yi Chen, Chien-Hung Chen, Yi-Hsiang Huang

J Formos Med Assoc· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between everolimus combination therapy and cancer risk after liver transplantation: A nationwide population-based quasi-cohort study.
Suk-Chan Jang, Gi-Ae Kim, Young-Suk Lim, Hye-Lin Kim, Eui-Kyung Lee

Am J Transplant· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply.
Won-Mook Choi, Young-Suk Lim

Clin Gastroenterol Hepatol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic Effects of Transarterial Chemoembolization and Lenvatinib on HIF-1α Ubiquitination and Prognosis Improvement in Hepatocellular Carcinoma.
Sung Won Chung, Jin Sun Kim, Won-Mook Choi, Jonggi Choi, Danbi Lee, Young-Suk Lim

Clin Cancer Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Viral Replication Activity and Postoperative Recurrence of HBV-Related Hepatocellular Carcinoma.
Subin Heo, Jiwon Yang, Jeayeon Park, Rex Wan-Hin Hui, Byeong Geun Song, Young-Suk Lim

Aliment Pharmacol Ther· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Hepatic and Extrahepatic Outcomes of Chronic Hepatitis C Patients After Sofosbuvir-Based Treatment (LONGHEAD Study).
Chung-Feng Huang, Jeong Heo, Rong-Nan Chien, Yang-Hyun Baek, Jia-Horng Kao, Young-Suk Lim

Infect Dis Ther· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined Transarterial Chemoembolization and External Beam Radiotherapy for Identifying Surgical Candidates for Hepatocellular Carcinoma with Macroscopic Vascular Invasion: A Propensity Score-Weighted Analysis.
Sumin Lee, Jinhong Jung, Jonggi Choi, So Yeon Kim, Jin Hyoung Kim, Young-Suk Lim

Cancer Res Treat· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Variceal Bleeding in Patients Receiving Atezolizumab-Bevacizumab Treatment for Hepatocellular Carcinoma.
Kanghee Park, Hye Won Lee, Euichang Kim, Won-Mook Choi, Danbi Lee, Young-Suk Lim

Aliment Pharmacol Ther· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION): interim results from a randomised controlled trial.
Young-Suk Lim, Ming-Lung Yu, Jonggi Choi, Chi-Yi Chen, Won-Mook Choi

Lancet Gastroenterol Hepatol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher Risk of Proteinuria with Atezolizumab plus Bevacizumab than Lenvatinib in First-Line Systemic Treatment for Hepatocellular Carcinoma.
Jiwon Yang, Won-Mook Choi, Hyung-Don Kim, Jonggi Choi, Changhoon Yoo, Young-Suk Lim

Liver Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atezolizumab plus Bevacizumab Is Associated with Favorable Overall Survival over Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma.
Hyung-Don Kim, Young-Gyu Park, Hyeyeon Hong, Sung Won Chung, Sejin Kim, Young-Suk Lim

Oncology· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic body radiotherapy alone versus stereotactic body radiotherapy after incomplete transarterial therapy for hepatocellular carcinoma.
Youngju Song, Jinhong Jung, Jin-Hong Park, So Yeon Kim, Jonggi Choi, Young-Suk Lim

J Med Imaging Radiat Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on the treatment navigation for functional cure of chronic hepatitis B: Expert consensus 2.0.
Di Wu, Jia-Horng Kao, Teerha Piratvisuth, Xiaojing Wang, Patrick T F Kennedy, Young-Suk Lim

Clin Mol Hepatol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eight-year efficacy and safety of tenofovir alafenamide for treatment of chronic hepatitis B virus infection: Final results from two randomised phase 3 trials.
Maria Buti, Young-Suk Lim, Henry Lik Yuen Chan, Kosh Agarwal, Patrick Marcellin, X Shalimar

Aliment Pharmacol Ther· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study.
Man-Fung Yuen, Young-Suk Lim, Ki Tae Yoon, Tien-Huey Lim, Jeong Heo

Lancet Gastroenterol Hepatol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis